Scarlett Gomez, PhD, MPH (left), examines Bay Area cancer rates. Photo by Noah Berger

New UCSF Study to Find out What Drives Cancer in Asian Americans

UC San Francisco researchers have received $12.45 million from the National Cancer Institute (NCI) to lead the first long-term study of cancer among Asian Americans, a highly diverse yet understudied group.

Physicians, researchers, and health care professionals from over 100 countries attend a poster session at the 59th ASCO Annual Meeting. Photo by © ASCO/Luke Franke 2023.

Latest Cancer Center DEIA Mini-Grants to Foster Career Development

The Cancer Center’s Office of Diversity, Equity, Inclusion, and Accessibility (DEIA) has awarded a new round of grants to support career development activities for faculty, staff, and trainees across the UCSF cancer community.

Prostate Cancer Study: More Health Benefits from Plant-Based Diet

Eating more fruits, nuts, and vegetables each day – along with fewer animal products – is associated with a nearly 50% reduction in the risk of prostate cancer progression.

Targeted Therapy, Treatment Disparity Featured at Cancer Meeting

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s annual meeting of the American Association for Cancer Research (AACR) conference.

Engineered T-cells designed to attack glioblastoma. Image by Payal Watchmaker.

Gene Therapy Is Halting Cancer. Can It Work Against Brain Tumors?

Grant of up to $11 million will fund a clinical trial at UCSF that uses a smarter new CAR-T guided by precision technology.

UCSF at AACR 2024

Advances in targeted therapy, cancer genomics and eliminating treatment disparities among the topics that will be presented by leading cancer researchers from UC San Francisco at this year’s annual meeting of the American Association for Cancer Research (AACR) conference.

T cells attacking glioblastoma. Image by Payal Watchmaker

UCSF Scientists Build a Molecular ‘GPS’ to Guide Cell Therapies

Wendell Lim earns $30 million contract from ARPA-H to develop a cellular toolkit for therapies targeting diseases of the brain and lung.

Image of neuroblastoma cells, the most common solid cancer found in children younger than age 5. Credit: The Cell Image Library / CC BY 3.0

New Pediatric Cancer Marker, New Hope for a Treatment Target

Researchers find Achilles heel of neuroblastoma, which accounts for 15% of all pediatric cancer deaths.

Can a New Drug Candidate Cure Pancreatic Cancer?

Scientists have designed a molecule that disarms a cancer-causing mutation found in several cancers, including lung, breast and colon.

Targeted Treatment of Rare Childhood Leukemia

UCSF researcher to lead multicenter precision medicine trial for juvenile myelomonocytic leukemia.

A microscopy of fluorescent T cells in a skin cancer carcionma

In Judo Move, Scientists Use Cancer’s Strength to Fight Against It

A genetic mutation that makes cancer cells hardy can be engineered into T cells, giving them superhuman strength.

See Us Portrait Project 2024 collage UCSF Cancer

See Us Portrait Campaign

The latest in a continuous series of portraits and quotes from UCSF Cancer Services staff and faculty, the See Us Portrait Project highlights underrepresented minority faculty and staff who are dedicated leaders in diversity, equity, and inclusion at the Cancer Center.